← Back to Clinical Trials
Recruiting NCT06623799

NCT06623799 Impact of Help-Seeking Behaviors on Allergic Rhinitis and Mental Health: A Longitudinal Study

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06623799
Status Recruiting
Phase
Sponsor QHSLab, Inc.
Condition Mental Health Conditions
Study Type OBSERVATIONAL
Enrollment 200,000 participants
Start Date 2020-01-01
Primary Completion 2027-01-25

Eligibility & Interventions

Sex All sexes
Min Age 4 Years
Max Age 100 Years
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 200,000 participants in total. It began in 2020-01-01 with a primary completion date of 2027-01-25.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study explores how help-seeking behaviors for both emotional well-being and allergies impact the management of allergic rhinitis, asthma, and mental health symptoms, including anxiety and depression. The research involves a retrospective and longitudinal analysis of patients who sought treatment for allergic rhinitis and mental health concerns. The goal is to highlight the importance of integrating mental health care into allergy treatment plans to improve overall patient outcomes.

Eligibility Criteria

Inclusion Criteria: Adults (aged 18 years or older) Patients actively receiving care in a primary care setting. Patients who have provided informed consent for their health data to be included in the research repository. Exclusion Criteria: Patients who have not provided informed consent for their health data to be included in the research repository. Patients diagnosed with chronic conditions outside the scope of allergic rhinitis, asthma, or mental health conditions (anxiety, depression). Patients with severe mental health disorders or comorbidities that are unrelated to the conditions of interest (e.g., schizophrenia, bipolar disorder, etc.).

Contact & Investigator

Central Contact

Marcos A Sanchez-Gonzalez, MD, PhD

✉ masanchez@qhslab.com

📞 850-559-7676

Frequently Asked Questions

Who can join the NCT06623799 clinical trial?

This trial is open to participants of all sexes, aged 4 Years or older, up to 100 Years, studying Mental Health Conditions. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06623799 currently recruiting?

Yes, NCT06623799 is actively recruiting participants. Contact the research team at masanchez@qhslab.com for enrollment information.

Where is the NCT06623799 trial being conducted?

This trial is being conducted at West Palm Beach, United States.

Who is sponsoring the NCT06623799 clinical trial?

NCT06623799 is sponsored by QHSLab, Inc.. The trial plans to enroll 200,000 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology